Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare business, in a deal that could yield billions of dollars for the French drugmaker.
More Stories
After AMD’s AI event, this analyst says Nvidia’s stock is the better play
Despite underperformance for AMD shares this year and major outperformance for Nvidia shares, a Bernstein analyst said he’d rather get...
U.S. consumer sentiment ticks lower in early October as nation holds breath prior to election
Michigan index dips to 68.9, well below forecast of 71
Wholesale prices flatten out and signal low inflation in guts of the economy
U.S. wholesale prices were unchanged in September and pointed to subdued inflation in the economy.
Tesla’s robotaxi event is ‘stunningly absent on detail,’ sending stock lower
Analysts saw a fun display of technology from Elon Musk but noted the company left out details on pricing and...
Boeing files NLRB unfair-labor-practice charge against union amid ongoing machinist strike
“The union violated its duty to bargain in good faith by engaging in regressive bargaining, surface bargaining, misrepresenting deal terms...
BlackRock’s assets hit record high of $11.5 trillion
Blackrock’s assets under management were boosted by a surge in inflows driven by billions pouring in from exchange-traded-funds